Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27Kip1 at G1 phase

被引:354
|
作者
Kamura, T
Hara, T
Matsumoto, M
Ishida, N
Okumura, F
Hatakeyama, S
Yoshida, M
Nakayama, K
Nakayama, KI
机构
[1] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cell Biol, Higashi Ku, Fukuoka 8128582, Japan
[2] Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan
[3] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res Human Dis, Dept Dev Biol, Sendai, Miyagi 9808575, Japan
[4] RIKEN, Discovery Res Inst, Chem Genet Lab, Wako, Saitama 3510198, Japan
关键词
D O I
10.1038/ncb1194
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The cyclin-dependent kinase inhibitor p27(Kip1) is degraded at the G0-G1 transition of the cell cycle by the ubiquitin proteasome pathway(1,2). Although the nuclear ubiquitin ligase (E3) SCFSkp2 is implicated in p27(Kip1) degradation(3-6), proteolysis of p27(Kip1) at the G0 - G1 transition proceeds normally in Skp2(-/-) cells(7,8). Moreover, p27(Kip1) is exported from the nucleus to the cytoplasm at G0 - G1 ( refs 9 - 11). These data suggest the existence of a Skp2- independent pathway for the degradation of p27(Kip1) at G1 phase. We now describe a previously unidentified E3 complex: KPC ( Kip1 ubiquitination- promoting complex), consisting of KPC1 and KPC2. KPC1 contains a RING- finger domain, and KPC2 contains a ubiquitinlike domain and two ubiquitin- associated domains. KPC interacts with and ubiquitinates p27Kip1 and is localized to the cytoplasm. Overexpression of KPC promoted the degradation of p27(Kip1), whereas a dominant- negative mutant of KPC1 delayed p27(Kip1) degradation. The nuclear export of p27(Kip1) by CRM1 seems to be necessary for KPC- mediated proteolysis. Depletion of KPC1 by RNA interference also inhibited p27(Kip1) degradation. KPC thus probably controls degradation of p27(Kip1) in G1 phase after export of the latter from the nucleus.
引用
收藏
页码:1229 / 1235
页数:7
相关论文
共 50 条
  • [41] Cyclin D1 regulates p27KiP1 stability in B cells
    Bustany, Sophie
    Tchakarska, Guergana
    Sola, Brigitte
    CELLULAR SIGNALLING, 2011, 23 (01) : 171 - 179
  • [42] p27Kip1 inhibits the cell cycle through non-canonical G1/S phase-specific gatekeeper mechanism
    Sharma, Savitha S.
    Ma, Le
    Pledger, W. Jackson
    CELL CYCLE, 2015, 14 (24) : 3954 - 3964
  • [43] Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression
    Chassot, A-A
    Turchi, L.
    Virolle, T.
    Fitsialos, G.
    Batoz, M.
    Deckert, M.
    Dulic, V.
    Meneguzzi, G.
    Busca, R.
    Ponzio, G.
    ONCOGENE, 2007, 26 (39) : 5772 - 5783
  • [44] Histidine Triad Nucleotide-binding Protein 1 Up-regulates Cellular Levels of p27KIP1 by Targeting ScfSKP2 Ubiquitin Ligase and Src
    Cen, Bo
    Li, Haiyang
    Weinstein, I. Bernard
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (08) : 5265 - 5276
  • [45] Expression of the ubiquitin ligase subunit cyclin kinase subunit 1 and its relationship to S-phase kinase protein 2 and p27Kip1 in prostate cancer
    Shapira, Ma'anit
    Ben-Izhak, Ofer
    Slotky, Merav
    Goldin, Oleg
    Lahav-Baratz, Shirly
    Hershko, Dan D.
    JOURNAL OF UROLOGY, 2006, 176 (05): : 2285 - 2289
  • [46] Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas
    Hershko, D
    Bornstein, G
    Ben-Izhak, O
    Carrano, A
    Pagano, M
    Krausz, MM
    Hershko, A
    CANCER, 2001, 91 (09) : 1745 - 1751
  • [47] p27Kip1 and Ser10-phosphorylated p27Kip1 in breast cancer: clinical significance and expression
    Song, Wei
    Xie, Ruilian
    Zhu, Aiyu
    Xu, Yumei
    Shi, Yaqin
    Shen, Yan
    Zhang, Wenwen
    Yang, Fang
    Guan, Xiaoxiang
    ONCOTARGETS AND THERAPY, 2015, 8 : 1863 - 1869
  • [48] p27Kip1 knockout mice are protected from diabetic nephropathy:: Evidence for p27Kip1 haplotype insufficiency
    Wolf, G
    Schanze, A
    Stahl, RAK
    Shankland, SJ
    Amann, K
    KIDNEY INTERNATIONAL, 2005, 68 (04) : 1583 - 1589
  • [49] Targeting the p27Kip1 E3 ubiquitin ligase for the treatment of multiple myeloma and other hematological malignancies.
    Chen, Qing
    Xie, Weilin
    Kuhn, Deborah J.
    Voorhees, Peter M.
    Mendy, Derek
    Lopez-Girona, Antonia
    Plantevin, Veronique
    Xu, Weiming
    De Parseval, Laura
    Corral, Laura G.
    Glezer, Emilia
    Chan, Kyle
    Mercurio, Frank
    Orlowski, Robert Z.
    BLOOD, 2006, 108 (11) : 114A - 114A
  • [50] TRIP6 regulates p27KIP1 to promote ovarian tumorigenesis
    Lin, Fang-Tsyr
    Lin, Victor T. G.
    Lin, Vivian Y.
    Lai, Yun-Ju
    Chen, Chen-Shan
    Liu, Kang
    Lin, Weei-Chin
    CLINICAL CANCER RESEARCH, 2015, 21